Management of Left Main Coronary Artery Stenosis
The Internet Journal of Cardiology · 2003
DOI: 10.5580/1111 ↗At a glance
Journal article in The Internet Journal of Cardiology, 2003.
Abstract (original language)
The optimal treatment of left main coronary artery disease (LMD) continues to evolve and remains a topic for exciting scientific debate. As a large segment of the myocardium depends on this vessel, adequate perfusion is necessary for a proper function of the heart. The available modalities for management of LMD include pharmacotherpay, bypass surgery or nonsurgical percutaneous revascularisation. Medical therapy of patients with LMD is associated with a poor prognosis (1,2,3). However, randomized trials and large registries (4,5,6,7,8,9,10) have shown improved survival by coronary artery bypass graft surgery (CABGS) and generally this technique has remained the preferred therapeutic option. Gruntzig et al (11) reported the first percutaneous interventions of left main coronary artery (LMCA) and concluded that the technical difficulties and high early mortality made this unacceptable as a standard treatment. As a result in 1984, the National Heart Lung and Blood Institute published a consensus document that percutaneous transluminal coronary angioplasty (PTCA) was contraindicated for this subset (12).
Cite
APA
(2003). Management of Left Main Coronary Artery Stenosis. The Internet Journal of Cardiology. https://doi.org/10.5580/1111
Vancouver
Management of Left Main Coronary Artery Stenosis. The Internet Journal of Cardiology. 2003. doi:10.5580/1111
BibTeX
@article{euvimed2003,
title = {Management of Left Main Coronary Artery Stenosis},
journal = {The Internet Journal of Cardiology},
year = {2003},
doi = {10.5580/1111}
}
EUVIMED